India's Pharmaceutical Exports

Country Profile

Algeria

Algeria is a growing market for Indian pharmaceuticals — $134M in FY 2025–26, with 2.9× growth over the past decade. Medicines accounts for 52% of shipments, with vaccines contributing $18.9M. The compound annual growth rate since FY2015 stands at 10.3%.

🇩🇿 $134M · 2.9× growth since FY2015 · 10.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$134M
Exports FY2025–26 DGCIS
2.9×
Growth FY2015→2026
10.3%
CAGR FY2015→2026
52%
Medicines Share
5
Product Categories Supplied
Algeria is a growing market for Indian pharmaceuticals — $134M in FY 2025–26, with 2.9× growth over the past decade. Medicines accounts for 52% of shipments, with vaccines contributing $18.9M. The compound annual growth rate since FY2015 stands at 10.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $69.8M (52.2%) Medicine Ingredients $34.5M (25.8%) Vaccines $18.9M (14.1%) Surgical & Hospital Supplies $6.73M (5.0%) Traditional & Herbal $3.89M (2.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Algeria in the RBI overseas direct investment dataset (2011–2026).